Citation

Bensussan H, Mhamdi K. Ann. Cardiol. Angeiol. (Paris) 2020; 69(2): 103-106.

Copyright

(Copyright © 2020, Elsevier Publishing)

DOI

10.1016/j.ancard.2020.03.007

PMID

32223907

Abstract

This report presents the case of a young man of 24 years old with Asperger syndrome who ingest quantities of medication whose flecainide. Resume of his stay in intensive care unit, notably serious adverse effect which ventricular tachycardia with membrane stabilizing effect and lengthening of stay in intensive care unit. Study of literature of different take care already published, with notion of mid-term leaching of flecainide which were ingest days before, at different levels all over the world.

Language: fr

Keywords

Humans; Male; Young Adult; Length of Stay; Suicide, Attempted; Sedation; Anti-Arrhythmia Agents; Asperger Syndrome; Flecainide; Bicarbonates; Ventricular tachycardia; Effet stabilisant de membrane; Flecaine; Flécainide; Intoxication médicamenteuse volontaire; Membrane stabilizing effect; Sédation; Tachycardia, Ventricular; tachycardie ventriculaire; Ventilation; Voluntary medication intoxication